Heyman Richard A. Insider Trades

Insider Trading History

Track insider trading activity for Heyman Richard A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $1.17M 22,647 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$32.2k 1,230 shares
$26.18
$51.73
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $995k 19,234 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$522k 19,234 shares
$27.16
$51.73
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $1.27M 24,595 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$32.9k 1,230 shares
$26.75
$51.73
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $2.25M 213,072 shares
Last Trade
Jan 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$80.4k 6,700 shares
$12.00
$10.55
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $1.3M 25,107 shares
Last Trade
Jan 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$107k 4,285 shares
$25.00
$51.73
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $1.52M 29,392 shares
Last Trade
Jan 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$241k 9,635 shares
$25.03
$51.73
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $422k 40,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$327k 40,000 shares
$8.17
$10.55
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $478k 45,300 shares
Last Trade
Oct 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$379k 32,800 shares
$11.56
$10.55
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $551k 52,253 shares
Last Trade
Oct 03, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$379k 32,800 shares
$11.56
$10.55
PMV Pharmaceuticals
PMV Pharmaceuticals PMVP
Director
Holding Value $47.6k 33,500 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8k 33,500 shares
$0.95
$1.42
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $1.19M 23,014 shares
Last Trade
Feb 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$517k 23,014 shares
$22.47
$51.73
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $369k 35,000 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$289k 35,000 shares
$8.26
$10.55
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $6.4M 123,673 shares
Last Trade
Oct 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$47.1k 1,570 shares
$30.00
$51.73
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $6.44M 124,490 shares
Last Trade
Oct 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$35.1k 1,270 shares
$27.67
$51.73
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $6.51M 125,760 shares
Last Trade
Oct 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$77.7k 2,825 shares
$27.51
$51.73
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $6.65M 128,585 shares
Last Trade
Oct 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.3k 518 shares
$27.54
$51.73
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $6.68M 129,103 shares
Last Trade
Sep 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$28.5k 1,270 shares
$22.41
$51.73
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $6.78M 130,993 shares
Last Trade
Aug 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$29.5k 1,270 shares
$23.25
$51.73
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $6.81M 131,643 shares
Last Trade
Jul 31, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$64.7k 2,351 shares
$27.51
$51.73
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $6.9M 133,345 shares
Last Trade
Jul 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$31.5k 1,270 shares
$24.80
$51.73

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up